Less expense ratio implies better returns over the long term

Expense Ratio

ETF has been able to closely match its benchmark's returns

Tracking Error

ETF has been generating better price return than bank FD

Return vs FD Rates

Good time to consider, as ETF is not in overbought zone

Entry Point

The Nifty Pharma index closed 1.21 per cent up at 21419.65.

Stock market update: Nifty Pharma index advances 1.21%

The Nifty Pharma index was trading 1.14 per cent up at 21404.5.

Stock market update: Nifty Pharma index advances 1.14% in an upbeat market

Indian headline indices ended in the green for the second session in a row helped by strong buying action in most sectors. Auto, IT and pharma stocks were among the top gainers. While the S&P BSE Sensex settled at 76,532.96, up by 631.55 points or 0.83%, the broader Nifty closed at 23,163.10, higher by 205.85 points or 0.9%.Commenting on the day’s action, Rupak De, Senior Technical Analyst at LKP Securities said that the sentiment has improved over the past two days. “The Nifty moved up, shrugging off two days of weakness. Though sentiment has improved slightly, overall weakness is likely to persist as the index remains below the 21EMA. On the lower end, 23,000 is likely to act as immediate support, and a fall below this level might trigger panic in the market. However, above 23,200, the Nifty could gather more strength,” De said.Here are 5 stock recommendations for Thursday: Stock Ideas

Market Trading Guide: SRF, BPCL among 5 stock recommendations for Thursday - Stock Ideas

The Nifty Pharma index closed 1.77 per cent up at 21163.9.

Stock market update: Nifty Pharma index advances 1.77%

The Nifty Pharma index was trading 1.0 per cent up at 21004.5.

Stock market update: Nifty Pharma index advances 1.0% in an upbeat market

Aurobindo Pharma’s shares drop over 3% after FDA inspection results in VAI classification for subsidiary’s API plant.

Aurobindo Pharma shares decline after U.S. FDA inspection report to subsidiary’s API plant

The Nifty Pharma index closed 2.33 per cent down at 20796.6.

Stock market update: Nifty Pharma index falls 2.33%

Laurus Labs slumped 11.6%, Aurobindo declined 2%, Cipla fell 1.1% and Strides dropped 5%. Other pharma shares also declined with 19 out of 20 stocks on the Nifty Pharma index ending lower. The pharma index fell 2.7%, while the benchmark Nifty ended 1.1% lower on Monday.

US foreign aid ban hits HIV-related local drug stocks

The Nifty Pharma index closed 2.65 per cent down at 21292.3.

Stock market update: Nifty Pharma index falls 2.65%

The health ministry is set to meet pharma industry representatives to discuss improving drug quality after several instances of exports failing standards. The meeting on January 31 will also address ease of business concerns. Inspections have intensified following WHO’s link between Indian cough syrups and deaths in Gambia and a report highlighting numerous substandard drugs.

Drug quality, ease of doing biz to top govt-pharma companies’ talks

Stocks including Kotak Mahindra Bank, Dr Reddy’s Labs, Adani Green, IndiGo, Indus Towers, United Spirits, Mankind Pharma and more will be in the spotlight on Friday, January 24.

Stocks in news: Kotak Mahindra Bank, DRL, Adani Green, IndiGo, Indus Towers, Mankind Pharma

The ETF tracks Nifty Pharma Index which is designed to reflect the behavior and performance of the pharmaceutical sector in India.